Pharmaceutical
Pharmaceutical executive search & headhunting specialists
At Stone Executive, we partner with the organisations that discover, develop and deliver medicines, appointing the senior leaders who carry a product from laboratory to patient. Pharmaceutical recruitment is the search for the people who lead that journey: the managing directors, medical and regulatory leaders, commercial and market-access heads, and manufacturing and quality directors who run one of the world’s most regulated and consequential industries. Our network in the industry has been built appointment by appointment over years of pharmaceutical search, and we know that a strong CV is only the starting point. We identify the leaders who genuinely deliver where science, regulation and commerce meet.
Senior pharmaceutical executive search demands fluency in the industry’s own language, from trial design to payer strategy. The medical director who leads a clinical development programme is a very different appointment from the commercial leader who launches the product it produces, and a generalist process rarely accounts for that. Our consultants work closely with pharmaceutical companies large and small across the UK, from global names to the emerging businesses clustered around Cambridge, Oxford and London, which gives them a real understanding of where the talent sits and how to reach it. This is specialist Pharma recruitment, part of our wider life sciences practice, applied to the appointments that determine whether medicines reach the patients who need them.
Pharmaceutical leaders we appoint
Most of our assignments in this sector sit at director and board level, where a single appointment shapes how a portfolio is developed, approved and commercialised. We appoint across the full pharmaceutical lifecycle, from the leaders who run development to those who manufacture and sell the finished medicine.
- Managing directors and general managers leading pharmaceutical companies, country organisations and divisions, supported by our board level practice.
- Medical directors and heads of clinical development who design and lead trial programmes.
- Regulatory affairs, quality and pharmacovigilance leaders who take products through approval and keep them compliant.
- Commercial, marketing and market-access directors who launch medicines and secure reimbursement.
- Manufacturing, supply chain and technical operations leaders who make and deliver at scale.
Areas we cover
Pharmaceuticals is not a single discipline, and the right leader in clinical development is rarely the obvious appointment in commercial operations or manufacturing. Stone Executive recruits across the full range of functions found in a modern pharmaceutical business, and across therapy areas from oncology and rare disease to vaccines and consumer health, matching each search to consultants who understand that specific market.
- Clinical development & medical affairs
- Regulatory affairs & quality
- Commercial, marketing & market access
- Manufacturing & technical operations (CDMO)
- Business development & licensing
- Generics, biosimilars & consumer health
This is the pharmaceutical industry across development, approval and commercialisation. Where a brief sits closer to the science end of the market, our biotech practice works alongside us, and for devices and diagnostics our medical device practice leads, so the right leader is appointed to the right remit.
What is changing in Pharmaceutical leadership
The pharmaceutical industry is being reshaped, and the appointments organisations make now reflect it. Science has shifted towards biologics, cell and gene therapies and precision medicine, pricing and market access have become as decisive as clinical data, and artificial intelligence is beginning to change how molecules are discovered and trials are run. Together they have redrawn the brief for senior pharmaceutical leadership.
The shift is visible in every specification we take. Where organisations once wanted deep functional expertise alone, they now look for leaders who can integrate science, regulation and commercial strategy, and who are comfortable partnering across biotech, academia and health systems. The organisations that appoint for that breadth are the ones that keep their pipelines moving.
Why specialist Pharmaceutical search matters
Senior pharmaceutical appointments carry a deceptive amount of risk: the credentials can look right while the fit is wrong. A brilliant scientist does not always make a medical director, and a strong sales leader is not necessarily the person to build a market-access strategy for a novel therapy. A search that screens for the CV rather than the fit with the portfolio, the culture and the regulatory demands of the role is the usual reason a senior appointment disappoints, and at this level the cost is measured in delayed programmes and missed launches, not simply salary.
Specialist knowledge is the safeguard. Our consultants live in the life sciences market, so they recognise the difference between functional competence and leadership that can carry a portfolio, a launch or a business, and they bring that judgement to bear before the search begins, which is what makes the eventual shortlist dependable. It is the same research-led discipline that runs through all of our wider executive search work.
Our Pharmaceutical search process
Our Pharmaceutical recruitment engagements run to a defined four-stage method, weighted to the seniority of the role and the nature of the business. A named consultant leads the engagement from first conversation to appointment, supported by our in-house research team, and the four stages below move in order, with timing shaped by the organisation’s availability and the discretion the search requires.
Understanding the role. We begin with the chief executive, board or leaders who own the appointment, building a clear picture of the organisation’s portfolio and pipeline, its regulatory position, the culture, and what the right person needs to achieve. For a medical or commercial director appointment, that includes a candid conversation about where the pipeline really stands and what the role must unlock.
Mapping the market. Drawing on our network and structured research, we identify the pharmaceutical leaders who genuinely fit, across competitor companies, biotech and the adjacent sectors where the right experience can be found. Senior moves in a well-connected industry are sensitive, so this stage is handled with particular discretion.
Approaching candidates. The pharmaceutical leaders worth appointing are rarely looking; they are running programmes and portfolios and are rewarded accordingly. They will, however, take a serious call from a consultant they respect, made in confidence, about a role genuinely worth hearing about, and that is the conversation we know how to open.
Shortlist to appointment. We bring the search down to a short, defensible list, each candidate presented with a written assessment of their scientific, regulatory and commercial strengths, their leadership record, and how they measure against the brief. From there we manage the process through interviews and any assessment required, and on to offer and acceptance.
FAQs
What is the highest paying job in pharma?›
At the top of the industry, the chief executives and country managing directors of major pharmaceutical companies are the highest paid, with total reward running into seven figures at the largest groups. Below board level, medical directors, heads of clinical development and senior commercial and market-access leaders command the strongest packages, reflecting the scarcity of people who combine scientific credibility with commercial judgement.
What are the biggest pharmaceutical companies in the UK?›
The UK is home to two of the world’s largest pharmaceutical companies, AstraZeneca and GSK, both headquartered and listed here. Alongside them, most global pharmaceutical groups run substantial UK organisations, and a deep field of speciality pharma, generics and emerging biotech companies operates across the country, particularly in the golden triangle of Cambridge, Oxford and London. Together they make the UK one of Europe’s most important life sciences markets.
What are the phases of clinical trials?›
Clinical trials typically run through four phases. Phase one tests safety in a small group, phase two explores effectiveness and dosing, phase three confirms results in large patient populations, and phase four monitors a medicine after approval. Leading these programmes is the responsibility of clinical development and medical leadership, and the calibre of those leaders has a direct bearing on how quickly a medicine reaches patients.
Which roles are most in demand in pharmaceutical companies?›
Demand is strongest for leaders in medical affairs, regulatory affairs, market access and health economics, where scientific and commercial judgement meet. Cell and gene therapy, biologics manufacturing and real-world evidence are growing specialisms with shallow talent pools. At executive level, general managers who can run a country organisation through launch, and leaders who bridge biotech partnering and big-pharma discipline, are consistently the hardest appointments to fill.
What does a medical director do in pharma?›
A medical director leads a pharmaceutical company’s medical strategy, overseeing clinical development, medical affairs and the scientific integrity of how its products are studied and communicated. The role bridges the science and the business: advising on trial design, engaging clinicians and regulators, and ensuring commercial activity is medically sound. It is one of the most senior and scarce appointments in the industry, almost always held by a qualified physician.
To discuss a managing director, medical or commercial director, or senior pharmaceutical appointment, please contact our team on 0333 800 1560.
If you would like to discuss a vacancy, or you're looking for a new opportunity, please send us an email or give us a call - we'd be delighted to hear from you.
